Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Skin Neoplasms × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 6 Neoplasms 5 Breast Neoplasms 4 Vomiting 2 Solid Tumors 2 Neoplasm Metastasis 2 Weight Gain 1 Venous Thromboembolism 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1 Skin Toxicity 1 Skin Neoplasms 1 Renal Insufficiency 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Parathyroid Neoplasms 1 Nausea 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1

Interventions

aldesleukin 8 Interleukin-2 8 Dacarbazine 6 fludarabine phosphate 5 Cyclophosphamide 5 fludarabine 4 Temozolomide 4 Nivolumab 4 Ipilimumab 4 montanide ISA 51 3 Surveys and Questionnaires 3 Semaxinib 3 Radiotherapy 3 Radiation 3 Fluorouracil 3 Educational Status 3 zanolimumab 2 sonidegib 2 poly ICLC 2 binimetinib 2 Whole-Body Irradiation 2 Vinblastine 2 Vemurafenib 2 Surgical Procedures, Operative 2 Spectrum Analysis, Raman 2 Sodium Chloride 2 Photochemotherapy 2 Peptides 2 Optical Imaging 2 Mohs Surgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00083239 2007-06-08

Study of Talabostat in Advanced Melanoma

Point Therapeutics

Phase 2 Completed

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡